References

Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline

10.1164/rccm.201807-1255st · 2018 · External reference

Molecular biomarkers in idiopathic pulmonary fibrosis: state of the art and future directions

10.3390/ijms22126255 · External reference

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

10.1056/nejmoa1402582 · 2014 · External reference

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

10.1056/nejmoa1402584 · 2014 · External reference

Evaluating disease severity in idiopathic pulmonary fibrosis

10.1183/16000617.0051-2017 · 2017 · External reference

Idiopathic pulmonary fibrosis: best practice in monitoring and managing a relentless fibrotic disease

10.1159/000504763 · 2020 · External reference

Forced vital capacity in idiopathic pulmonary fibrosis—FDA review of pirfenidone and nintedanib

10.1056/nejmp1500526 · 2015 · External reference

Meaningful endpoints for idiopathic pulmonary fibrosis (IPF) clinical trials: emphasis on ‘feels, functions, survives’. Report of a collaborative discussion in a symposium with direct engagement from representatives of patients, investigators, the National Institutes of Health, a patient advocacy organization, and a regulatory agency

10.1164/rccm.202312-2213so · 2024 · External reference

High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis

10.1164/rccm.200412-1756oc · 2005 · External reference

Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis

10.1183/13993003.01384-2018 · 2018 · External reference

Development and validation of a CT-based deep learning algorithm to augment non-invasive diagnosis of idiopathic pulmonary fibrosis

10.1016/j.rmed.2023.107428 · 2023 · External reference

e-Lung computed tomography biomarker stratifies patients at risk of idiopathic pulmonary fibrosis progression in a 52-week clinical trial

10.1164/rccm.202312-2274le · 2024 · External reference

The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference

10.1136/thx.2009.113498 · 2010 · External reference

Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference

10.1164/rccm.201105-0840oc · 2011 · External reference

Minimal clinically important difference in the 6-minute-walk distance for patients with pulmonary arterial hypertension

10.1164/rccm.202208-1547oc · 2023 · External reference

Prediction of idiopathic pulmonary fibrosis progression using early quantitative changes on CT imaging for a short term of clinical 18-24-month follow-ups

10.1007/s00330-019-06402-6 · 2020 · External reference

One-year change in quantitative computed tomography is associated with meaningful outcomes in fibrotic lung disease

10.1164/rccm.202503-0535oc · 2025 · External reference

Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline

10.1164/rccm.202202-0399st · 2022 · External reference

Comparison of shallow and deep learning methods on classifying the regional pattern of diffuse lung disease

10.1007/s10278-017-0028-9 · 2018 · External reference

Lung segmentation on HRCT and volumetric CT for diffuse interstitial lung disease using deep convolutional neural networks

10.1007/s10278-019-00254-8 · 2019 · External reference

Maximally selected rank

2002 · External reference

Proteomic biomarkers of survival in idiopathic pulmonary fibrosis

10.1164/rccm.202301-0117oc · 2024 · External reference

A quantitative imaging measure of progressive pulmonary fibrosis

10.1164/rccm.202501-0208oc · 2025 · External reference

Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis

10.1136/thoraxjnl-2021-218440 · 2023 · External reference

Evaluating the yield of medical tests

10.1001/jama.1982.03320430047030 · 1982 · External reference

Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach

10.1002/sim.6370 · 2015 · External reference

High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis

10.1186/1465-9921-15-10 · 2014 · External reference

Automated computed tomography analysis in the assessment of idiopathic pulmonary fibrosis severity and progression

10.1016/j.ejrad.2020.108852 · 2020 · External reference

CT quantification of interstitial lung abnormality and interstitial lung disease: from technical challenges to future directions

10.1097/rli.0000000000001103 · 2025 · External reference

Imaging research in fibrotic lung disease; applying deep learning to unsolved problems

10.1016/s2213-2600(20)30003-5 · 2020 · External reference

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper

10.1016/s2213-2600(17)30433-2 · 2018 · External reference

Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT

10.1136/thoraxjnl-2015-207252 · 2016 · External reference

Computer recognition of regional lung disease patterns

10.1164/ajrccm.160.2.9804094 · 1999 · External reference

Quantitative computed tomography imaging of interstitial lung diseases

10.1097/rti.0b013e3182a21969 · 2013 · External reference

Computed tomographic biomarkers in idiopathic pulmonary fibrosis. The future of quantitative analysis

10.1164/rccm.201803-0444pp · 2019 · External reference

Enhancement of semantic segmentation by image-level fine-tuning to overcome image pattern imbalance in HRCT of diffuse infiltrative lung diseases

10.1002/ima.23188 · 2024 · External reference

Measurement variability of same-day CT quantification of interstitial lung disease: a multicenter prospective study

10.1148/ryct.230287 · 2024 · External reference

Quantitative CT measurements of interstitial lung disease: same-day variability between two vendors-a prospective study

10.2214/ajr.25.34057 · 2026 · External reference